C4 Therapeutics Inc (NASDAQ:CCCC) currently has a daily average trading volume of 1.07M but it saw 774409 shares traded in last market. With a market cap of 89.47M USD, the company’s current market price of $1.26 came falling about -3.08 while comparing to the previous closing price of $1.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.66 and as low as $1.09. In the recent trading on the day, stock has struck highest price mark of $1.24 while lowest mark touched by it was $1.31.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which upgraded the stock as “Overweight” in its note to investors issued on December 19, 2024, recommending a price target of between $8 and $12 for it. JP Morgan also issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, CCCC’s stock price is moving -14.86% down while it is -22.22% when we observe its performance for the past one month. Year-to-date it is -65.00% down and over the past year, the stock is showing a downside performance of -77.38%.
Currently, C4 Therapeutics Inc’s total number of outstanding shares is 70.99M with 9.79% of that held by the insiders while 92.06% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -40.73% and return on equity (ROE) at -45.55%. Stock’s beta reads 2.95. Stock has a price to book (P/B) ratio of 0.46 while price to sale or P/S ratio amounts to 2.25. Its return on asset (ROA) is -28.77% on average.
